Local Institution

Louisville, Kentucky 40207

0 studies enrolling now · 27 studies all time

What they study most

AIDS, Bipolar Disorder, Bladder Cancer, Bladder Neoplasms, Body Weight Change, Breast Cancer, Cancer, Carcinoma, Non-Small-Cell Lung, Congestive Heart Failure, Coronary Artery Disease, Diabetes Mellitus, Diabetes Mellitus II

Studies at this site

• A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread — Completed
• Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma — Completed
• Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer — Completed
• An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer — Withdrawn before enrolling
• Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma — NO_LONGER_AVAILABLE
• A Study to Examine MPI SPECT Imaging With BMS068645 and Adenosine Compared to Coronary Angiography — Stopped early
• A Comparison Study of Apadenoson and Adenosine to Treadmill Exercise Stress. — Stopped early
• A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and Paclitaxel — Withdrawn before enrolling
• Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve) — Completed
• Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder — Completed
• Aripiprazole in Patients With Acute Mania — Completed
• Study of Aripiprazole in Patients With a History of Bipolar Disorder — Completed
• Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder — Completed
• Aripiprazole Open-Label, Safety and Tolerability Study — Completed
• PPAR - Combination With Metformin — Completed
• Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia — Completed
• Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy — Completed
• A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis — Completed
• Rollover Study for Zerit (Stavudine) ER Studies (-096, -099) — Completed
• Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects — Completed
• A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis — Stopped early
• Dose Ranging Study With LT, Monotherapy, PPAR — Completed
• Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes — Completed
• A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer — Stopped early
• Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium — Completed
• A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate — Completed
• A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen — Completed